Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Eris Lifesciences Limited Call Transcript 2024

Feb 6, 2024

61253_rns_2024-02-06_3ae5c7cb-c758-486c-9fe8-c22fdea7abd6.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [594 x 125] intentionally omitted <==

Date: 06 February 2024

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (“SEBI (LODR) Regulations, 2015”)

Dear Sir/Madam,

This is further to our letter dated 06[th] February 2024, intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31, 2023.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Tuesday, February 13, 2024, at 04:30 p.m. IST. The details of the said call are attached herewith and is also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

Digitally signed by MILIND TALEGAONKAR MILIND DN: c=IN, postalCode=380055, st=GUJARAT, street=E42 SHRI SADAN SHAHWADI VASNAAHMEDABADOPP SWAMINARAYAN2BEHIND GB SHAH COLLEGE 380055, l=AHMEDABAD, o=Personal, title=6609, serialNumber=a508a80d3a9231304a5bf4e4182bcd5ae3ec1d08a TALEGAONKA 10919025e2d5daa95b04426, pseudonym=660920220924180430743, 2.5.4.20=57785628ba3ced9959cf93cf3cf172cf4a41a51eb72e155a 16f1b8fb6276b3d4, R email=[email protected], cn=MILIND TALEGAONKAR Date: 2024.02.06 20:34:57 +05'30'

_________________________ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.: a/a

==> picture [592 x 72] intentionally omitted <==

==> picture [114 x 63] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Webcast

To discuss the financial and operational

performance for

Q3 & 9M FY 24

Day/Date: Tuesday, 13[th] February, 2024

Time: 4:30 PM, IST

Registration Link

Register with the below link and join:

We look forward to your participation RSVP: Kruti Raval: [email protected]